A Biphasic Pattern of Reproductive Hormones in Healthy Female Infants: The COPENHAGEN Minipuberty Study

J Clin Endocrinol Metab. 2022 Aug 18;107(9):2598-2605. doi: 10.1210/clinem/dgac363.

Abstract

Context: Minipuberty, a period of a transient activation of the hypothalamic-pituitary-gonadal (HPG) axis in both sexes, enables evaluation of gonadal function in infants suspected of hypogonadism. However, female minipuberty remains poorly elucidated.

Objective: We aimed to establish continuous reference ranges for the most commonly used reproductive hormones and to evaluate the dynamics of the HPG axis in females aged 0 to 1 year.

Design: The COPENHAGEN Minipuberty Study (ClinicalTrials.gov ID: NCT02784184), a longitudinal, prospective cohort study.

Setting: Healthy infants from Copenhagen.

Patients or other participants: A total of 98 healthy, term female infants followed with 6 examinations including venipuncture during the first year of life.

Intervention(s): None.

Main outcome measure(s): Serum concentrations of LH, FSH, inhibin B, anti-Müllerian hormone (AMH), estrone (E1), estradiol (E2), and SHBG were quantified using highly sensitive methods in 266 serum samples.

Results: Reference ranges were established for LH, FSH, inhibin B, AMH, E1, E2, and SHBG. Two peaks were observed in normalized mean curves for all hormones. The first peaks were timed around postnatal days 15 to 27 followed by a general nadir for all hormones around days 58 to 92. The second peaks occurred around days 107 to 125 for inhibin B, AMH, E1, E2, and SHBG and days 164 to 165 for LH and FSH.

Conclusions: We present age-related, continuous reference ranges of the most commonly used reproductive hormones and present novel data revealing a biphasic and prolonged female minipuberty.

Clinicaltrials.gov id: NCT02784184.

Keywords: HPG axis; female; hypothalamic-pituitary-gonadal axis; minipuberty; reference ranges; reproductive hormones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Mullerian Hormone
  • Estradiol
  • Female
  • Follicle Stimulating Hormone
  • Humans
  • Hypogonadism*
  • Infant
  • Inhibins*
  • Prospective Studies

Substances

  • Estradiol
  • Inhibins
  • Anti-Mullerian Hormone
  • Follicle Stimulating Hormone

Associated data

  • ClinicalTrials.gov/NCT02784184